**Updated: Recuro Health Announces $15M Series A Round
The virtual health platform company continues growth with round led by ARCH Venture Partners and continued support from existing investors including the Oklahoma Life Science Fund and Cortado Ventures
Cortado Ventures is pleased to congratulate portfolio company Recuro Health on their $15 million Series A led by ARCH Venture Partners, with follow-on support from existing Seed Round-investors including Oklahoma Life Science Fund (OLSF), 1843 Capital, Sage Ventures, and Cortado Ventures. Founded in 2021, Recuro has grown its virtual health platform to include its May acquisition of SupDoc, an AI-enabled telehealth startup with a holistic, cost-effective model for care delivery. With these funds, Recuro will continue its ongoing acquisition strategy and market expansion, as well as to further build upon growth.
“This new round of funding demonstrates our market-leading position in the digital health solutions space. The continued confidence of investors in our innovative approach to solving some of the most pressing challenges in healthcare and the strength of our management team will lead us forward in the year ahead,” Michael Gorton, CEO and founder of Recuro Health, said in a statement.
“Cortado funds companies that aim to transform industries. This is why we invested alongside OLSF who led Recuro’s seed financing, and why we’re more than doubling our investment in the current round.” —Mike Moradi, Recuro board member, Cortado venture partner
Formerly founded Teledoc
Gorton previously founded Dallas-based Teladoc (NYSE:TDOC) and led it as CEO and chairman for its first seven years of operation. Several other leaders with Teladoc experience have now joined Recuro.
“Recuro Health, led by the founding Teladoc team that helped create the digital health category over twenty years ago, is disrupting the traditional healthcare delivery system by advancing integrated care, risk stratification and diagnostics,” said Robert Nelsen, co-founder and managing director of ARCH Venture Partners.
Integrated care team approach
Recuro’s digital health model takes an integrated care team approach, addressing primary care and behavioral health issues with a unified group of primary care physicians, psychiatrists, and counselors. It also offers consumers a curated suite of virtual, fully customizable solutions to monitor and support their health, from home testing to screening capabilities to genetic testing.
Ultimately, the team wants to transition the U.S. healthcare system from a reactive, disease-focused model to a population health outcomes approach. Recuro wants all patients to have a way to engage with physicians, receive personalized care, and manage their health, no matter their location or situation.
This summer, Recuro released a COVID-19 rapid testing solution that enables employers to get access to many of the latest FDA Emergency Use Authorization-approved COVID rapid tests. It generated wide receptivity among federal and state governments and corporate healthcare decision-makers, according to Gorton.
“Recuro healthcare solutions occur at the intersection of quality, access and affordability, delivering appropriate care at the right time and place,” Gorton says. “We are particularly gratified with our strong capabilities and responsiveness to assist with safe return-to-work requirements nationwide.”
**Update: An earlier version omitted the Oklahoma Life Science Fund (OLSF) who sourced and led the earlier seed round.